H-1B sponsorship profile: NGM Biopharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, NGM Biopharmaceuticals, Inc filed 9 Labor Condition Applications covering 9 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (9 certified of 9 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on NGM Biopharmaceuticals, Inc’s H-1B petitions range from $101,816 at the low end to $140,300 at the high end, with a petition-weighted average of $116,022. That range reflects the mix of occupations the company sponsors, led by Senior Scientist (2 petitions at $136,150 avg), followed by Sr. Research Associate II and Sr. Clinical Trial Management Associate. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. NGM Biopharmaceuticals, Inc is headquartered in South San Francisco, CA under NAICS code 54171, and places H-1B workers across 2 states, most heavily in CA, AZ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where NGM Biopharmaceuticals, Inc ranks. By H-1B petition volume, NGM Biopharmaceuticals, Inc is #17,879 of 119,880 employers nationally and #2,836 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.